
    
      1. The prognosis of childhood acute lymphoblastic leukemia(ALL) has been increased.

        2. Tyrosine Kinase Inhibitor(TKI) has improved Philadelphia chromosome positive (Ph+)ALL
           treatment outcome.

        3. The prognosis of high-risk childhood ALL except for Philadelphia chromosome positive
           (Ph+)ALL is very bad.
    
  